Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TM-MC* | |||
NPO22244 | Terminalia bellirica | Species | Combretaceae | Eukaryota | TM-MC* | |||
NPO26650 | Terminalia chebula | Species | Combretaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 17538.81 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 24099.05 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 30408.85 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 49317.38 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 16672.47 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 27227.01 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 7430.19 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 36391.5 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 52480.75 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 36391.5 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 18030.18 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 27289.78 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 16672.47 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 23933.16 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 20511.62 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 13520.73 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 26181.83 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 33728.73 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 28840.32 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 16982.44 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 15922.09 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 27669.42 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 69662.65 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 36897.76 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 37931.5 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 14028.14 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 21627.19 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 3349.65 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 17458.22 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 14621.77 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 36559.48 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 17988.71 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 16865.53 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 33806.48 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 18535.32 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 15995.58 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 59841.16 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 17338.04 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 26363.31 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 30199.52 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 27797.13 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 56493.7 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 18535.32 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 34119.29 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 13740.42 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 13551.89 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 30408.85 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 95499.26 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 4385.31 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 35075.19 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC173872 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC119094 |
0.9884 | High Similarity | NPC7839 |
0.9884 | High Similarity | NPC142291 |
0.9649 | High Similarity | NPC80956 |
0.9532 | High Similarity | NPC297574 |
0.9489 | High Similarity | NPC201814 |
0.9425 | High Similarity | NPC123259 |
0.9425 | High Similarity | NPC129533 |
0.9419 | High Similarity | NPC472723 |
0.9322 | High Similarity | NPC269046 |
0.9322 | High Similarity | NPC477083 |
0.9322 | High Similarity | NPC477081 |
0.9318 | High Similarity | NPC261623 |
0.9318 | High Similarity | NPC111490 |
0.927 | High Similarity | NPC472721 |
0.927 | High Similarity | NPC31208 |
0.927 | High Similarity | NPC160543 |
0.927 | High Similarity | NPC93065 |
0.927 | High Similarity | NPC472720 |
0.927 | High Similarity | NPC469652 |
0.927 | High Similarity | NPC472724 |
0.9266 | High Similarity | NPC237202 |
0.9261 | High Similarity | NPC231254 |
0.9257 | High Similarity | NPC8940 |
0.9227 | High Similarity | NPC3474 |
0.9222 | High Similarity | NPC477082 |
0.9213 | High Similarity | NPC240200 |
0.9213 | High Similarity | NPC158214 |
0.9213 | High Similarity | NPC223534 |
0.9213 | High Similarity | NPC290289 |
0.9209 | High Similarity | NPC469650 |
0.9195 | High Similarity | NPC473713 |
0.9191 | High Similarity | NPC219600 |
0.9191 | High Similarity | NPC34436 |
0.9191 | High Similarity | NPC263119 |
0.9191 | High Similarity | NPC166674 |
0.9191 | High Similarity | NPC473550 |
0.9191 | High Similarity | NPC46640 |
0.9186 | High Similarity | NPC181778 |
0.9186 | High Similarity | NPC470272 |
0.9181 | High Similarity | NPC311389 |
0.9181 | High Similarity | NPC470271 |
0.9162 | High Similarity | NPC187632 |
0.9157 | High Similarity | NPC65489 |
0.9157 | High Similarity | NPC469649 |
0.9157 | High Similarity | NPC260521 |
0.9148 | High Similarity | NPC208797 |
0.9148 | High Similarity | NPC53680 |
0.9123 | High Similarity | NPC175793 |
0.9116 | High Similarity | NPC476358 |
0.9111 | High Similarity | NPC97924 |
0.9111 | High Similarity | NPC471091 |
0.9111 | High Similarity | NPC264302 |
0.9111 | High Similarity | NPC40078 |
0.907 | High Similarity | NPC43918 |
0.907 | High Similarity | NPC261411 |
0.907 | High Similarity | NPC473818 |
0.907 | High Similarity | NPC190204 |
0.904 | High Similarity | NPC170203 |
0.904 | High Similarity | NPC125352 |
0.9023 | High Similarity | NPC65333 |
0.9017 | High Similarity | NPC149300 |
0.9016 | High Similarity | NPC189312 |
0.8989 | High Similarity | NPC135831 |
0.8989 | High Similarity | NPC297503 |
0.8989 | High Similarity | NPC97119 |
0.8983 | High Similarity | NPC198902 |
0.8977 | High Similarity | NPC67629 |
0.8977 | High Similarity | NPC79736 |
0.8966 | High Similarity | NPC47521 |
0.896 | High Similarity | NPC31034 |
0.8947 | High Similarity | NPC291957 |
0.8947 | High Similarity | NPC14030 |
0.8944 | High Similarity | NPC475360 |
0.8927 | High Similarity | NPC267549 |
0.8914 | High Similarity | NPC38438 |
0.8914 | High Similarity | NPC100251 |
0.8908 | High Similarity | NPC198125 |
0.8908 | High Similarity | NPC197708 |
0.8908 | High Similarity | NPC658 |
0.8908 | High Similarity | NPC95421 |
0.8895 | High Similarity | NPC121290 |
0.8895 | High Similarity | NPC470898 |
0.8889 | High Similarity | NPC474093 |
0.8889 | High Similarity | NPC104910 |
0.8883 | High Similarity | NPC132111 |
0.8883 | High Similarity | NPC470718 |
0.8871 | High Similarity | NPC470450 |
0.8864 | High Similarity | NPC98583 |
0.884 | High Similarity | NPC97817 |
0.884 | High Similarity | NPC269625 |
0.884 | High Similarity | NPC179947 |
0.884 | High Similarity | NPC475179 |
0.884 | High Similarity | NPC72554 |
0.884 | High Similarity | NPC30011 |
0.884 | High Similarity | NPC105591 |
0.8833 | High Similarity | NPC470713 |
0.8833 | High Similarity | NPC25946 |
0.8833 | High Similarity | NPC470720 |
0.8833 | High Similarity | NPC460984 |
0.8833 | High Similarity | NPC21359 |
0.8833 | High Similarity | NPC470717 |
0.882 | High Similarity | NPC113836 |
0.882 | High Similarity | NPC476620 |
0.882 | High Similarity | NPC476622 |
0.882 | High Similarity | NPC37668 |
0.882 | High Similarity | NPC476618 |
0.882 | High Similarity | NPC476623 |
0.882 | High Similarity | NPC476619 |
0.882 | High Similarity | NPC253521 |
0.882 | High Similarity | NPC258044 |
0.882 | High Similarity | NPC267680 |
0.882 | High Similarity | NPC217387 |
0.882 | High Similarity | NPC196127 |
0.882 | High Similarity | NPC293626 |
0.882 | High Similarity | NPC476621 |
0.8817 | High Similarity | NPC174140 |
0.8814 | High Similarity | NPC473630 |
0.8807 | High Similarity | NPC47140 |
0.8807 | High Similarity | NPC102851 |
0.8807 | High Similarity | NPC5786 |
0.8807 | High Similarity | NPC67134 |
0.8791 | High Similarity | NPC473618 |
0.8791 | High Similarity | NPC205721 |
0.8785 | High Similarity | NPC473554 |
0.8785 | High Similarity | NPC295625 |
0.8785 | High Similarity | NPC112380 |
0.8785 | High Similarity | NPC470719 |
0.8778 | High Similarity | NPC241781 |
0.8778 | High Similarity | NPC156785 |
0.8778 | High Similarity | NPC162394 |
0.8771 | High Similarity | NPC471030 |
0.8771 | High Similarity | NPC472726 |
0.8771 | High Similarity | NPC472725 |
0.8764 | High Similarity | NPC144097 |
0.8764 | High Similarity | NPC61904 |
0.8757 | High Similarity | NPC175230 |
0.8757 | High Similarity | NPC88560 |
0.8757 | High Similarity | NPC163165 |
0.8757 | High Similarity | NPC172033 |
0.875 | High Similarity | NPC204937 |
0.875 | High Similarity | NPC149011 |
0.8729 | High Similarity | NPC249560 |
0.8729 | High Similarity | NPC223860 |
0.8729 | High Similarity | NPC470416 |
0.8729 | High Similarity | NPC49690 |
0.8729 | High Similarity | NPC275977 |
0.8729 | High Similarity | NPC318119 |
0.8728 | High Similarity | NPC285108 |
0.8728 | High Similarity | NPC33298 |
0.8722 | High Similarity | NPC117668 |
0.8722 | High Similarity | NPC469371 |
0.8721 | High Similarity | NPC289346 |
0.8721 | High Similarity | NPC24627 |
0.8721 | High Similarity | NPC24164 |
0.8715 | High Similarity | NPC477895 |
0.8715 | High Similarity | NPC217520 |
0.8715 | High Similarity | NPC35167 |
0.8715 | High Similarity | NPC472387 |
0.8715 | High Similarity | NPC139571 |
0.8713 | High Similarity | NPC238419 |
0.8713 | High Similarity | NPC172419 |
0.8708 | High Similarity | NPC34267 |
0.8708 | High Similarity | NPC81042 |
0.8708 | High Similarity | NPC253685 |
0.8708 | High Similarity | NPC214621 |
0.8708 | High Similarity | NPC171706 |
0.8708 | High Similarity | NPC223426 |
0.8681 | High Similarity | NPC221140 |
0.8681 | High Similarity | NPC473686 |
0.8681 | High Similarity | NPC475352 |
0.8681 | High Similarity | NPC475220 |
0.8681 | High Similarity | NPC33083 |
0.8681 | High Similarity | NPC87583 |
0.8681 | High Similarity | NPC229817 |
0.8678 | High Similarity | NPC67959 |
0.8674 | High Similarity | NPC36138 |
0.8674 | High Similarity | NPC321916 |
0.8667 | High Similarity | NPC212290 |
0.8663 | High Similarity | NPC37502 |
0.8663 | High Similarity | NPC87317 |
0.8663 | High Similarity | NPC40702 |
0.8663 | High Similarity | NPC267627 |
0.8659 | High Similarity | NPC268533 |
0.8659 | High Similarity | NPC472992 |
0.8659 | High Similarity | NPC472991 |
0.8655 | High Similarity | NPC239019 |
0.8655 | High Similarity | NPC104983 |
0.8655 | High Similarity | NPC300845 |
0.8655 | High Similarity | NPC247629 |
0.8655 | High Similarity | NPC250436 |
0.8655 | High Similarity | NPC318432 |
0.8655 | High Similarity | NPC291948 |
0.8655 | High Similarity | NPC88803 |
0.8652 | High Similarity | NPC316539 |
0.8652 | High Similarity | NPC472993 |
0.8644 | High Similarity | NPC52598 |
0.8644 | High Similarity | NPC285197 |
0.8636 | High Similarity | NPC298847 |
0.8636 | High Similarity | NPC45400 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC173872 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9023 | High Similarity | NPD7993 | Clinical (unspecified phase) |
0.8655 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8538 | High Similarity | NPD1465 | Phase 2 |
0.85 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.85 | High Similarity | NPD7808 | Phase 3 |
0.8492 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8444 | Intermediate Similarity | NPD7251 | Discontinued |
0.8436 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8436 | Intermediate Similarity | NPD7472 | Approved |
0.8418 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8418 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8418 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.838 | Intermediate Similarity | NPD7054 | Approved |
0.838 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8352 | Intermediate Similarity | NPD8313 | Approved |
0.8352 | Intermediate Similarity | NPD8312 | Approved |
0.8324 | Intermediate Similarity | NPD7228 | Approved |
0.8324 | Intermediate Similarity | NPD3818 | Discontinued |
0.8138 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8128 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.8114 | Intermediate Similarity | NPD8455 | Phase 2 |
0.8079 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8071 | Intermediate Similarity | NPD8151 | Discontinued |
0.8056 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD7199 | Phase 2 |
0.8034 | Intermediate Similarity | NPD6234 | Discontinued |
0.8 | Intermediate Similarity | NPD6232 | Discontinued |
0.7968 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7967 | Intermediate Similarity | NPD7473 | Discontinued |
0.7955 | Intermediate Similarity | NPD37 | Approved |
0.7946 | Intermediate Similarity | NPD7240 | Approved |
0.7944 | Intermediate Similarity | NPD6959 | Discontinued |
0.7923 | Intermediate Similarity | NPD3751 | Discontinued |
0.7921 | Intermediate Similarity | NPD4966 | Approved |
0.7921 | Intermediate Similarity | NPD4965 | Approved |
0.7921 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7853 | Intermediate Similarity | NPD1934 | Approved |
0.7849 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7829 | Intermediate Similarity | NPD1653 | Approved |
0.7814 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7802 | Intermediate Similarity | NPD3787 | Discontinued |
0.7765 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7754 | Intermediate Similarity | NPD6559 | Discontinued |
0.7722 | Intermediate Similarity | NPD3882 | Suspended |
0.7709 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.768 | Intermediate Similarity | NPD3749 | Approved |
0.768 | Intermediate Similarity | NPD7075 | Discontinued |
0.767 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7638 | Intermediate Similarity | NPD7435 | Discontinued |
0.7635 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7635 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7611 | Intermediate Similarity | NPD7819 | Suspended |
0.7611 | Intermediate Similarity | NPD2801 | Approved |
0.7596 | Intermediate Similarity | NPD5494 | Approved |
0.7576 | Intermediate Similarity | NPD6779 | Approved |
0.7576 | Intermediate Similarity | NPD6781 | Approved |
0.7576 | Intermediate Similarity | NPD6778 | Approved |
0.7576 | Intermediate Similarity | NPD6782 | Approved |
0.7576 | Intermediate Similarity | NPD6777 | Approved |
0.7576 | Intermediate Similarity | NPD6780 | Approved |
0.7576 | Intermediate Similarity | NPD6776 | Approved |
0.7569 | Intermediate Similarity | NPD5402 | Approved |
0.7569 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.755 | Intermediate Similarity | NPD7697 | Approved |
0.755 | Intermediate Similarity | NPD7680 | Approved |
0.755 | Intermediate Similarity | NPD7698 | Approved |
0.755 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7542 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7527 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7525 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7514 | Intermediate Similarity | NPD1512 | Approved |
0.7514 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7512 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7512 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7512 | Intermediate Similarity | NPD8319 | Approved |
0.7512 | Intermediate Similarity | NPD7870 | Phase 2 |
0.75 | Intermediate Similarity | NPD7411 | Suspended |
0.75 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7874 | Approved |
0.7488 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7486 | Intermediate Similarity | NPD6190 | Approved |
0.7459 | Intermediate Similarity | NPD6801 | Discontinued |
0.7429 | Intermediate Similarity | NPD3750 | Approved |
0.7401 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7401 | Intermediate Similarity | NPD1511 | Approved |
0.7389 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7387 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7387 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7379 | Intermediate Similarity | NPD7801 | Approved |
0.7374 | Intermediate Similarity | NPD5403 | Approved |
0.7371 | Intermediate Similarity | NPD8434 | Phase 2 |
0.736 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7356 | Intermediate Similarity | NPD7266 | Discontinued |
0.7323 | Intermediate Similarity | NPD6534 | Approved |
0.7323 | Intermediate Similarity | NPD6535 | Approved |
0.7303 | Intermediate Similarity | NPD6799 | Approved |
0.7287 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7282 | Intermediate Similarity | NPD8150 | Discontinued |
0.7273 | Intermediate Similarity | NPD8127 | Discontinued |
0.7267 | Intermediate Similarity | NPD230 | Phase 1 |
0.7263 | Intermediate Similarity | NPD5401 | Approved |
0.7253 | Intermediate Similarity | NPD6599 | Discontinued |
0.7232 | Intermediate Similarity | NPD4628 | Phase 3 |
0.723 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7209 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD1613 | Approved |
0.7198 | Intermediate Similarity | NPD3226 | Approved |
0.7198 | Intermediate Similarity | NPD7458 | Discontinued |
0.7175 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7175 | Intermediate Similarity | NPD6674 | Discontinued |
0.7167 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7166 | Intermediate Similarity | NPD919 | Approved |
0.7163 | Intermediate Similarity | NPD5619 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD3748 | Approved |
0.7092 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7072 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7072 | Intermediate Similarity | NPD2534 | Approved |
0.7072 | Intermediate Similarity | NPD2533 | Approved |
0.7072 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7072 | Intermediate Similarity | NPD2532 | Approved |
0.7053 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7033 | Intermediate Similarity | NPD6273 | Approved |
0.7018 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7017 | Intermediate Similarity | NPD7390 | Discontinued |
0.7 | Intermediate Similarity | NPD1247 | Approved |
0.6995 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.699 | Remote Similarity | NPD7549 | Discontinued |
0.6986 | Remote Similarity | NPD7585 | Approved |
0.6977 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD1510 | Phase 2 |
0.6944 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD7003 | Approved |
0.6944 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6938 | Remote Similarity | NPD7583 | Approved |
0.6936 | Remote Similarity | NPD3027 | Phase 3 |
0.6931 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6931 | Remote Similarity | NPD6213 | Phase 3 |
0.6931 | Remote Similarity | NPD6212 | Phase 3 |
0.6915 | Remote Similarity | NPD5353 | Approved |
0.691 | Remote Similarity | NPD2796 | Approved |
0.6907 | Remote Similarity | NPD7177 | Discontinued |
0.6897 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD6798 | Discontinued |
0.6893 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6893 | Remote Similarity | NPD7097 | Phase 1 |
0.6879 | Remote Similarity | NPD4908 | Phase 1 |
0.6875 | Remote Similarity | NPD1933 | Approved |
0.6875 | Remote Similarity | NPD447 | Suspended |
0.6866 | Remote Similarity | NPD4287 | Approved |
0.6854 | Remote Similarity | NPD651 | Clinical (unspecified phase) |
0.6851 | Remote Similarity | NPD8166 | Discontinued |
0.6839 | Remote Similarity | NPD5242 | Approved |
0.6818 | Remote Similarity | NPD943 | Approved |
0.6818 | Remote Similarity | NPD4060 | Phase 1 |
0.6816 | Remote Similarity | NPD5408 | Approved |
0.6816 | Remote Similarity | NPD5405 | Approved |
0.6816 | Remote Similarity | NPD1551 | Phase 2 |
0.6816 | Remote Similarity | NPD6099 | Approved |
0.6816 | Remote Similarity | NPD5404 | Approved |
0.6816 | Remote Similarity | NPD6100 | Approved |
0.6816 | Remote Similarity | NPD5406 | Approved |
0.681 | Remote Similarity | NPD7211 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD3764 | Approved |
0.68 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6791 | Remote Similarity | NPD7930 | Approved |
0.678 | Remote Similarity | NPD7667 | Clinical (unspecified phase) |
0.678 | Remote Similarity | NPD6355 | Discontinued |
0.6777 | Remote Similarity | NPD7584 | Approved |
0.6768 | Remote Similarity | NPD7039 | Approved |
0.6768 | Remote Similarity | NPD7038 | Approved |
0.6761 | Remote Similarity | NPD6233 | Phase 2 |
0.6737 | Remote Similarity | NPD4288 | Approved |
0.6733 | Remote Similarity | NPD6841 | Approved |
0.6733 | Remote Similarity | NPD6842 | Approved |
0.6733 | Remote Similarity | NPD6843 | Phase 3 |
0.6725 | Remote Similarity | NPD9269 | Phase 2 |
0.6723 | Remote Similarity | NPD1240 | Approved |
0.6722 | Remote Similarity | NPD2935 | Discontinued |
0.672 | Remote Similarity | NPD920 | Approved |
0.6717 | Remote Similarity | NPD5953 | Discontinued |
0.6705 | Remote Similarity | NPD3268 | Approved |
0.6703 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD5710 | Approved |
0.6701 | Remote Similarity | NPD5711 | Approved |
0.6685 | Remote Similarity | NPD5124 | Phase 1 |
0.6685 | Remote Similarity | NPD2346 | Discontinued |
0.6685 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6683 | Remote Similarity | NPD8285 | Discontinued |
0.6682 | Remote Similarity | NPD8059 | Phase 3 |
0.6682 | Remote Similarity | NPD8058 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4111 | Phase 1 |
0.6667 | Remote Similarity | NPD5005 | Approved |
0.6667 | Remote Similarity | NPD5006 | Approved |
PubChem CID   | 250397 |
ChEMBL   | CHEMBL1970427 |
ZINC   |
Molecular Weight:   | 954.10 |
ALogP:   | -6.8232 |
MLogP:   | 3 |
XLogP:   | -1.67 |
# Rotatable Bonds:   | 18 |
Polar Surface Area:   | 447.09 |
# H-Bond Aceptor:   | 15 |
# H-Bond Donor:   | 13 |
# Rings:   | 8 |
# Heavy Atoms:   | 68 |